ZBH
51
-2
M
28
-3
CVX
29
-3
BEN
36
-2
NFLX
76
3
STT
67
-4
ALLE
57
2
AMAT
54
-3
PWR
76
2
CMS
57
4
MPC
44
2
AMG
47
-5
KMB
51
-2
TDC
62
3
PVH
43
-2
APD
47
3
HSIC
48
-2
LMT
62
3
ETR
77
6
TRIP
40
-4
ZBH
51
-2
M
28
-3
CVX
29
-3
BEN
36
-2
NFLX
76
3
STT
67
-4
ALLE
57
2
AMAT
54
-3
PWR
76
2
CMS
57
4
MPC
44
2
AMG
47
-5
KMB
51
-2
TDC
62
3
PVH
43
-2
APD
47
3
HSIC
48
-2
LMT
62
3
ETR
77
6
TRIP
40
-4
Financhill
Back

NovoCure Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

NVCR
NovoCure

Last Price:
$19.12
Seasonality Move:
3.27%

7 Day Trial

ALL ACCESS PASS

$ 7

NovoCure Stock Forecast

  • Over the next 52 weeks, NovoCure has on average historically risen by 33.5% based on the past 9 years of stock performance.
  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is NovoCure Stock Undervalued?
    The current NovoCure [NVCR] share price is $19.11. The Score for NVCR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will NovoCure Stock Go Up Next Year?

  • Over the next 52 weeks, NovoCure has on average historically risen by 33.5% based on the past 9 years of stock performance.

NovoCure Stock Rating

Sell
33
NovoCure (NVCR) is a Sell

Is NovoCure overpriced?

  • NovoCure has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

NovoCure Stock Price History

Is NVCR stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Jersey
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com

52-Week Data

52-Week High:
34.13
52-Week Low:
14.17

Prediction Charts

Market Cap:
2.1B
Price in USD:
19.11
Volume:
1.1M
Beta:
1.05

Technical Analysis

SMA50:
17.72
SMA100:
20.56
SMA200:
20.23
52-Wk Change:
-14.19%

Stock Predictions

  • Is NovoCure stock public?
    Yes, NovoCure is a publicly traded company.
  • What is the NovoCure stock quote today?
    The NovoCure stock price is 19.11 USD today.
  • How to buy NovoCure stock online?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 17.97 18.57 18.77 17.93
May-13 18.79 18.14 18.85 17.86
May-14 18.11 17.10 18.11 16.92
May-15 17.17 17.59 17.62 16.67
May-16 17.60 17.89 17.94 17.34
May-19 17.50 17.96 17.99 17.38
May-20 17.89 18.20 18.30 17.71
May-21 17.93 17.75 18.50 17.43
May-22 17.62 18.11 18.31 17.59
May-23 17.70 18.54 18.79 17.70
May-27 19.22 19.18 19.57 18.82
May-28 18.98 19.37 19.43 18.66
May-29 19.72 19.40 20.06 19.02
May-30 19.27 19.11 19.29 18.46

NovoCure Earnings

NovoCure Earnings Report: Per Share NovoCure Earnings Q1 Q2 Q3 and Q4 last year and next year.

NovoCure Forecast Revenue Growth

NovoCure Stock Analysis: Historical quarterly revenues per share for NovoCure and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.35 per share, and a decrease next year of $0.10 per share.

* NovoCure stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.